To assess the function of Smarcd3 in advanced pancreatic tumors driven by both RAS activation and p53 loss, we crossed Smarcd3f/f mice into two independent autochthonous models that enabled temporally distinct deletion of Smarcd3, either embryonically or in adult mice. This evidence concerns the gene SMARCD3 and pancreatic neoplasm.